|
1
|
Carosella ED, Moreau P, Lemaoult J and
Rouas-Freiss N: HLA-G: From biology to clinical benefits. Trends
Immunol. 29:125–132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jeong S, Park S, Park BW, Park Y, Kwon OJ
and Kim HS: Human leukocyte antigen-G (HLA-G) polymorphism and
expression in breast cancer patients. PLoS One. 9:e982842014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pistoia V, Morandi F, Wang X and Ferrone
S: Soluble HLA-G: Are they clinically relevant? Semin Cancer Biol.
17:469–479. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baudhuin J, Migraine J, Faivre V, Loumagne
L, Lukaszewicz AC, Payen D and Favier B: Exocytosis acts as a
modulator of the ILT4-mediated inhibition of neutrophil functions.
Proc Natl Acad Sci USA. 110:17957–17962. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Le Page ME, Goodridge JP, John E,
Christiansen FT and Witt CS: Killer Ig-like receptor 2DL4 does not
mediate NK cell IFN-gamma responses to soluble HLA-G preparations.
J Immunol. 192:732–740. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morandi F, Rizzo R, Fainardi E,
Rouas-Freiss N and Pistoia V: Recent advances in our understanding
of HLA-G biology: Lessons from a wide spectrum of human diseases. J
Immunol Res. 2016:43264952016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
da Silva GB, Silva TG, Duarte RA, Neto NL,
Carrara HH, Donadi EA, Gonçalves MA, Soares EG and Soares CP:
Expression of the classical and Nonclassical HLA molecules in
breast cancer. Int J Breast Cancer. 2013:2504352013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elliott RL, Jiang XP, Phillips JT, Barnett
BG and Head JF: Human leukocyte antigen G expression in breast
cancer: Role in immunosuppression. Cancer Biother Radiopharm.
26:153–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gal-Yam EN, Saito Y, Egger G and Jones PA:
Cancer epigenetics: Modifications, screening, and therapy. Annu Rev
Med. 59:267–280. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Chen X, Wang F, An X, Tang B,
Zhang X, Sun L and Li Z: Aberrant DNA methylation reprogramming in
bovine SCNT preimplantation embryos. Sci Rep. 6:303452016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu H and Zhang Y: Mechanisms and functions
of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev.
25:2436–2452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bird AP and Wolffe AP: Methylation-induced
repression-belts, braces, and chromatin. Cell. 99:451–454. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bestor TH: The DNA methyltransferases of
mammals. Hum Mol Genet. 9:2395–2402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bird A: DNA methylation patterns and
epigenetic memory. Genes Dev. 16:6–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amouroux R, Nashun B, Shirane K, Nakagawa
S, Hill PW, D'Souza Z, Nakayama M, Matsuda M, Turp A, Ndjetehe E,
et al: De novo DNA methylation drives 5hmC accumulation in mouse
zygotes. Nat Cell Biol. 18:225–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Kruijf EM, Sajet A, van Nes JG, Natanov
R, Putter H, Smit VT, Liefers GJ, van den Elsen PJ, van de Velde CJ
and Kuppen PJ: HLA-E and HLA-G expression in classical HLA class
I-negative tumors is of prognostic value for clinical outcome of
early breast cancer patients. J Immunol. 185:7452–7459. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okano M, Bell DW, Haber DA and Li E: DNA
methyltransferases Dnmt3a and Dnmt3b are essential for de novo
methylation and mammalian development. Cell. 99:247–257. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W,
Xie ZG, Shi L, He X, Jin SG, et al: The role of Tet3 DNA
dioxygenase in epigenetic reprogramming by oocytes. Nature.
477:606–610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deivendran S, Marzook H, Santhoshkumar TR,
Kumar R and Pillai MR: Metastasis-associated protein 1 is an
upstream regulator of DNMT3a and stimulator of insulin-growth
factor binding protein-3 in breast cancer. Sci Rep. 7:442252017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Collignon E, Canale A, Al Wardi C, Bizet
M, Calonne E, Dedeurwaerder S, Garaud S, Naveaux C, Barham W,
Wilson A, et al: Immunity drives TET1 regulation in cancer through
NF-κB. Sci Adv. 4:eaap73092018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu C, Zhang YL, Pan WW, Li XM, Wang ZW, Ge
ZJ, Zhou JJ, Cang Y, Tong C, Sun QY and Fan HY: CRL4 complex
regulates mammalian oocyte survival and reprogramming by activation
of TET proteins. Science. 342:1518–1521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Verloes A, Spits C, Vercammen M, Geens M,
LeMaoult J, Sermon K, Coucke W and Van de Velde H: The role of
methylation, DNA polymorphisms and microRNAs on HLA-G expression in
human embryonic stem cells. Stem Cell Res. 19:118–127. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paul P, Rouas-Freiss N, Khalil-Daher I,
Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG and
Carosella ED: HLA-G expression in melanoma: A way for tumor cells
to escape from immunosurveillance. Proc Natl Acad Sci USA.
95:4510–4515. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wiendl H, Mitsdoerffer M, Hofmeister V,
Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A and
Weller M: A functional role of HLA-G expression in human gliomas:
An alternative strategy of immune escape. J Immunol. 168:4772–4780.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ugurel S, Rebmann V, Ferrone S, Tilgen W,
Grosse-Wilde H and Reinhold U: Soluble human leukocyte antigen-G
serum level is elevated in melanoma patients and is further
increased by interferon-alpha immunotherapy. Cancer. 92:369–376.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Urosevic M, Willers J, Mueller B, Kempf W,
Burg G and Dummer R: HLA-G protein up-regulation in primary
cutaneous lymphomas is associated with interleukin-10 expression in
large cell T-cell lymphomas and indolent B-cell lymphomas. Blood.
99:609–617. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Urosevic M, Kurrer MO, Kamarashev J,
Mueller B, Weder W, Burg G, Stahel RA, Dummer R and Trojan A: Human
leukocyte antigen G up-regulation in lung cancer associates with
high-grade histology, human leukocyte antigen class I loss and
interleukin-10 production. Am J Pathol. 159:817–824. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lefebvre S, Antoine M, Uzan S, McMaster M,
Dausset J, Carosella ED and Paul P: Specific activation of the
non-classical class I histocompatibility HLA-G antigen and
expression of the ILT2 inhibitory receptor in human breast cancer.
J Pathol. 196:266–274. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Poláková K, Bandzuchová E, Kuba D and Russ
G: Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G
expression in human leukemia cell lines. Leuk Res. 33:518–524.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moreau P, Mouillot G, Rousseau P, Marcou
C, Dausset J and Carosella ED: HLA-G gene repression is reversed by
demethylation. Proc Natl Acad Sci USA. 100:1191–1196. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang S, Tang B, Fan C, Shi L, Zhang X,
Sun L and Li Z: Effect of DNMT inhibitor on bovine parthenogenetic
embryo development. Biochem Biophys Res Commun. 466:505–511. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Brueckner B, Garcia Boy R, Siedlecki P,
Musch T, Kliem HC, Zielenkiewicz P, Suhai S, Wiessler M and Lyko F:
Epigenetic reactivation of tumor suppressor genes by a novel
small-molecule inhibitor of human DNA methyltransferases. Cancer
Res. 65:6305–6311. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stresemann C, Brueckner B, Musch T,
Stopper H and Lyko F: Functional diversity of DNA methyltransferase
inhibitors in human cancer cell lines. Cancer Res. 66:2794–2800.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Elvidge GP, Glenny L, Appelhoff RJ,
Ratcliffe PJ, Ragoussis J and Gleadle JM: Concordant regulation of
gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase
inhibition: The role of HIF-1alpha, HIF-2alpha, and other pathways.
J Biol Chem. 281:15215–15226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang J, Zhang S, Wang Y, Cheng H, Hao L,
Zhai Y, Zhang Z, An X, Ma X, Zhang X, et al: Effect of TET
inhibitor on bovine parthenogenetic embryo development. PLoS One.
12:e01895422017. View Article : Google Scholar : PubMed/NCBI
|
